Syncope is a medical term for a sudden, brief loss of consciousness due to a decrease in blood flow to the brain. It is a common condition that affects millions of people worldwide. It can be caused by a variety of factors, including medication, dehydration, and low blood pressure. In some cases, it can be a sign of a more serious underlying condition. While syncope can be a frightening experience, there are treatments available to help manage the symptoms and reduce the risk of future episodes. One such treatment is reflex syncope supportive therapy (RSST). This article will explore the benefits of RSST and provide a comprehensive guide for doctors and patients.
Reflex syncope supportive therapy (RSST) is a treatment designed to reduce the frequency and severity of syncope episodes. It is based on the principle that certain reflexes can be triggered to help prevent or reduce the symptoms of syncope. The therapy involves stimulating the vagus nerve, which is located in the neck and is responsible for controlling the heart rate. Stimulating the nerve can help to regulate the heart rate and reduce the risk of syncope.
RSST is a non-invasive treatment that does not require the use of drugs or surgery. The treatment involves the use of a specialized device that is worn around the neck. This device sends a small electrical impulse to the vagus nerve, which helps to regulate the heart rate and reduce the risk of syncope. The device is typically worn for 15 minutes per day and can be used in combination with other treatments, such as medication and lifestyle changes.
RSST has been shown to be effective in reducing the frequency and severity of syncope episodes. Studies have shown that RSST can reduce the number of syncope episodes by up to 50%. Additionally, the therapy can reduce the severity of the episodes, making them less frightening and easier to manage. RSST is also a safe and non-invasive treatment that does not require the use of drugs or surgery. The therapy has few side effects and is generally well tolerated. Additionally, the device is easy to use and can be worn while performing daily activities.
RSST is typically recommended for individuals who have experienced multiple syncope episodes or have a history of syncope. It is also recommended for individuals who have not responded to other treatments, such as lifestyle changes and medications.
Reflex syncope supportive therapy (RSST) is a safe and non-invasive treatment that can help to reduce the frequency and severity of syncope episodes. The therapy involves the use of a specialized device that is worn around the neck and sends a small electrical impulse to the vagus nerve, which helps to regulate the heart rate and reduce the risk of syncope. RSST has been shown to be effective in reducing the frequency and severity of syncope episodes and is generally well tolerated with few side effects. RSST is typically recommended for individuals who have experienced multiple syncope episodes or have a history of syncope. It is important for doctors and patients to discuss the risks and benefits of RSST and determine if it is an appropriate treatment for their needs.
1.
Even when they are not paying attention, children are still learning.
2.
Study finds higher breast cancer rates in areas with more air pollution
3.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
4.
New Zealand and Australian breast cancer rates among the highest in the world, global study finds
5.
PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.
1.
Case-Based Learning on Functional Bone Marrow Recovery Following Sequential Immune Challenges
2.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
3.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
4.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
5.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
Understanding Cancer: Early Detection and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation